Microbiome-derived indole-3-propionic acid primes somatic stem cells for germline-like quality control via AMPK-mediated selection

Hypothesis

Gut‑derived indole‑3‑propionic acid (IPA) activates AMPK in somatic stem cells, triggering a germline‑like quality‑control program that removes damaged components through heightened piRNA‑mediated transposon silencing, selective mitophagy, and asymmetric segregation of cellular debris.

Mechanistic rationale

Recent work shows that the germline sustains its integrity across generations not by passive durability but by relentless culling of defective lineages at each reproductive bottleneck [[https://pmc.ncbi.nlm.nih.gov/articles/PMC9255434/]]. Key effectors include piRNA pathways, mitochondrial quality control via mitophagy, telomerase activity, and asymmetric stem‑cell division that segregates damage away from the immortal lineage [[https://www.annualreviews.org/content/journals/10.1146/annurev-genet-022123-040039]]. Telomerase reactivation experiments prove that somatic tissues can regain youthful function when supplied with germline tools [[https://pmc.ncbi.nlm.nih.gov/articles/PMC3057569/]][[https://pmc.ncbi.nlm.nih.gov/articles/PMC3918663/]], yet other germline safeguards remain untested in soma.

AMPK serves as a metabolic relay between soma and germline, mediating signals that establish germline stem‑cell quiescence [[https://doi.org/10.1101/2023.11.15.567172]]. Intriguingly, gut microbes produce IPA, a tryptophan‑derived metabolite that can activate AMPK in various cell types [[https://doi.org/10.1101/2024.08.30.610454]][[https://doi.org/10.1038/s41467-020-15119-w]][[https://www.science.org/doi/10.1126/sciadv.adw8410]]. We hypothesize that IPA‑driven AMPK activation in somatic stem cells reproduces the germline’s “cheating” arsenal: it upregulates piRNA biogenesis, promotes mitophagy of damaged mitochondria, and biases asymmetric division to eject oxidized proteins and DNA lesions.

Testable predictions

1. Chronic IPA supplementation in aged mice will increase AMPK phosphorylation in intestinal and hematopoietic stem cells.
2. These cells will show elevated piRNA pathway gene expression (e.g., Piwil2, Mili) and reduced retrotransposon transcripts.
3. Mitophagy markers (Pink1, Parkin, LC3‑II) will rise, accompanied by lower mitochondrial ROS.
4. Asymmetric division assays will reveal a higher proportion of stem cells segregating ubiquitinated protein aggregates to the differentiating daughter.
5. Functional readouts—telomere length stability, improved tissue histology, and extended median lifespan—will mirror those seen with germline‑specific telomerase overexpression.
6. Genetic ablation of AMPK in stem cells will abolish IPA’s effects, falsifying the hypothesis.

Experimental design

• Groups: young (3 mo), old (24 mo) wild‑type mice receiving control chow, old mice receiving IPA‑supplemented chow (0.1 % w/w), and old mice with stem‑cell‑specific AMPK knockout receiving IPA.
• Readouts (at 8 weeks): stem‑cell isolation, western blot for p‑AMPK, qPCR for piRNA factors, RNA‑seq for transposon expression, mito‑Keima assay for mitophagy, immunofluorescence for asymmetric segregation of p62 aggregates, telomere Q‑FISH, histology of gut and marrow, survival monitoring.
• Analysis: compare IPA‑treated old mice to controls; test interaction with AMPK knockout.

If IPA reproduces germline‑grade quality control in soma, we predict a rescued, healthier aged phenotype; failure to observe any of the predicted molecular or functional changes would refute the mechanism.